Biotech · Private company
Akeso
Track this companyFree. Adds Akeso to your Dealase workspace and tells you when its record changes.
Clinical trials65 recruiting or active
Pipeline programs13From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline13
- CadonilimabPhase 3 · Gastric / Gastroesophageal Junction AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- CAPOX regimenPhase 3 · Gastric / Gastroesophageal Junction AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- NivolumabPhase 3 · Gastric / Gastroesophageal Junction AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- PenpulimabPhase 3 · Nasopharyngeal CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- AK104Phase 2 · Recurrent Cervical CancerClinicalTrials.gov · fetched Nov 12, 2026
- AK112Phase 2 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- AK117Phase 2 · Higher-risk Myelodysplastic SyndromesClinicalTrials.gov · fetched Nov 12, 2026
- AK117Phase 2 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- AzacitidinePhase 2 · Higher-risk Myelodysplastic SyndromesClinicalTrials.gov · fetched Nov 12, 2026
- CapecitabinePhase 2 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- IrinotecanPhase 2 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- LeucovorinPhase 2 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- OxaliplatinPhase 2 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ AdenocarcinomaPHASE3 · RECRUITING · started Sep 24, 2026ClinicalTrials.gov NCT07700979 · fetched Nov 12, 2026
- A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic SyndromesPHASE2 · RECRUITING · started Feb 7, 2024ClinicalTrials.gov NCT06196203 · fetched Nov 12, 2026
- Phase III Study of AK112 for NSCLC PatientsPHASE3 · ACTIVE_NOT_RECRUITING · started May 4, 2023ClinicalTrials.gov NCT06396065 · fetched Nov 12, 2026
- A Study of AK112 With or Without AK117 in Metastatic Colorectal CancerPHASE2 · ACTIVE_NOT_RECRUITING · started Jun 27, 2022ClinicalTrials.gov NCT05382442 · fetched Nov 12, 2026
- A Study of Penpulimab (AK105) in the First-line Treatment of Recurrent or Metastatic Nasopharyngeal CarcinomaPHASE3 · ACTIVE_NOT_RECRUITING · started Aug 16, 2021ClinicalTrials.gov NCT04974398 · fetched Nov 12, 2026
- A Study of AK104, a PD-1/CTLA-4 Bispecific Antibody in Subjects With Recurrent/Metastatic Cervical CancerPHASE2 · COMPLETED · started Jul 15, 2020ClinicalTrials.gov NCT04380805 · fetched Nov 12, 2026